アクトによるRaf-MEK-ERK経路の差別化段階特異的阻害
C Rommel1, B A Clarke, S Zimmermann
1Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Science (New York, N.Y.)
|November 27, 1999
まとめ
フォスファディチルイノシトール3キナーゼ (PI3K) -アクト経路は,分化筋細胞ではRaf-MEK-ERK経路を阻害するが,前駆体ではそうではない. このステージ固有の阻害は,RafとAkt複合体の形成を含み,ユニークな媒介者を示唆しています.
科学分野:
- 分子生物学は分子生物学である.
- 細胞シグナル伝達 細胞信号伝達
- 筋肉生理学 筋肉生理学
背景:
- 細胞外信号は,Raf-MEK-ERKとPI3K-Aktの両経路を同時に活性化する.
- この2つの主要なシグナリングカスケードは,筋肉細胞高縮を調節する上で対極的な役割を果たしています.
- PI3K-Akt経路は,Raf-MEK-ERK経路をクロス調節し,抑制することが知られている.
研究 の 目的:
- PI3K-Akt経路によるRaf-MEK-ERK経路の微分調節を調査する.
- これらのシグナル伝達経路の間のクロストークにおける細胞分化状態の役割を決定する.
- AktとRafの抑制相互作用の基礎にある分子メカニズムを解明する.
主な方法:
- Raf-MEK-ERKとPI3K-Aktの信号伝達経路の同時活性化の分析.
- 微分化ミオチューブとミオブラスト前駆体における経路のクロス調節の評価.
- 抑制活動に関連してRafとAkt複合体の形成の調査.
主要な成果:
- Aktの活性化により,Raf-MEK-ERK経路は,ミオブラスト前駆体ではなく,特異化したミオチューブで抑制された.
- このステージ固有の阻害は,AktがRaf.と複合体を形成する能力と相関していた.
- 抑制性Akt-Raf複合体に対する差異的に発現する媒介体の存在が示唆されている.
結論:
- PI3K-AktとRaf-MEK-ERK経路の抑制的なクロストークは,筋肉細胞の分化状態に依存しています.
- AktのRaf-MEK-ERKシグナリングを阻害する能力は,Rafとの相互作用によって媒介され,Rafは細胞段階に特異的です.
- これらの発見は,筋肉細胞高縮の調節の複雑さを強調し,新しい治療目標を示唆しています.
さらに関連する動画
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
関連する概念動画
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...